An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A telehealth company called CoreAge Rx is adding two new therapies to what it offers online: sermorelin and NAD+ treatments. The announcement is basically a business update saying these services are now available through their virtual platform. It’s not a clinical trial or new approval — it’s a company expanding what it will provide to patients by telemedicine. Sermorelin is a synthetic version of a natural signal your body uses to tell the pituitary gland to release growth hormone. In simple terms, it nudges the body to make more of a hormone that tends to decline with age. NAD+ (nicotinamide adenine dinucleotide) is a molecule inside cells that helps with energy and metabolism. Some clinics sell NAD+ infusions or supplements to try to boost cellular energy, though the science around benefits in healthy people is still developing. The announcement doesn’t present new research data. It’s a rollout of services: CoreAge Rx will now offer remote consultations and treatments involving sermorelin and NAD+ through its telehealth setup. There’s no mention of large clinical trials, specific patient outcomes, or regulatory breakthroughs in the brief. So, this is a commercial availability update rather than evidence that these therapies are definitely effective for anti-aging or other claims. Why this could matter is practical: telehealth makes it easier for people to access specialty treatments without going to a clinic in person. People interested in hormone-related therapies or “biohacking” approaches to energy and aging might find it more convenient to get evaluations and prescriptions online. For patients in areas with few specialists, a telehealth option can broaden access. That said, there are important caveats. Sermorelin affects hormone systems and should be used only under medical supervision; it can have side effects and isn’t appropriate for everyone. NAD+ treatments vary widely in formulation and delivery (oral supplements versus IV infusions), and the clinical benefits for broad anti-aging use are not conclusively proven. Telehealth makes access easier but doesn’t change the need for careful medical evaluation. Also, availability via a private telehealth service is different from formal regulatory approval for a specific anti-aging indication. Bottom line: CoreAge Rx is now offering sermorelin and NAD+ services by telehealth, which may increase access, but this is a service expansion — not new proof these treatments work for aging.
Source: Barchart